Alamy Over the last several years, the news about Social Security's long-term health has gotten progressively worse. With nearly every passing year, the Social Security Administration's annual Trustees' Report has pulled forward the date when the Social Security Trust Funds are expected to run out of cash. About a year has passed since the last report, which pegged the date at 2033, and the next is due soon. Still, a collapse date 20 years from now wouldn't seem so bad if it weren't for the fact that the trend suggests it probably won't stay that far away, as the chart below illustrates: Trustee Report Year Estimated "Run Dry" Date 2012 2033 2011 2036 2010 2037 2009 2037 2008 2041 On top of that worrisome pattern, data published earlier this year by the Congressional Budget Office indicate that the Social Security Trust Funds' problems continue to get worse. A combination of higher disability claims, low interest rates, and stubbornly high unemployment have conspired to draw closer the date when the program's reserves will be exhausted. Based on that, chances are strong that this year's Trustees' Report will pull the funds' expiration date even sooner. Regardless of exactly when the projected date for the Trust Funds to run dry is, if nothing changes, those reserves are going to run out -- at which time, benefits will be cut. What Happens to You When It Runs Out of Reserves? The Social Security Trustees indicate that when the reserves are gone, incoming taxes will only be able to cover about 75 percent of the program's current promised benefits. Nobody is quite sure yet how that 75 percent will be distributed across beneficiaries, but chances are good that your benefits, along with everyone else's, will be affected by that shortfall. The average monthly Social Security check to a retiree currently sits at $1,265.82. While everyone's situation varies, a 25 percent cut in those benefits translates to a substantial loss in income.
Best Paper Companies To Buy For 2015: Taro Pharmaceutical Industries Ltd (TARO)
Taro Pharmaceutical Industries Ltd., incorporated in 1959, is a science-based pharmaceutical company. The Company develops manufactures, and markets prescription and over-the-counter (OTC) pharmaceutical products, primarily in the United States, Canada and Israel. The Company also develops and manufactures active pharmaceutical ingredients (APIs), primarily for use in its finished dosage form products. The Company�� primary areas of focus include pediatric creams and ointments, liquids, capsules and tablets, mainly in the dermatological and topical, cardiovascular, neuropsychiatric and anti-inflammatory therapeutic categories. The Company operates through three companies: Taro Pharmaceutical Industries Ltd. (Taro Israel), and two of its subsidiaries (including indirect), Taro Pharmaceuticals Inc. (Taro Canada) and Taro U.S.A. The Company markets more than 180 pharmaceutical products in over 25 countries.
Taro Israel manufactures more than 160 finished dosage form pharmaceutical products for sale in Israel and for export. It produces APIs used in the manufacture of finished dosage form pharmaceutical products. It markets and distributes generic products in the local Israeli market. Taro Israel�� primary product lines include dermatology, prescription and OTC semi-solid products (creams, ointments and gels) and liquids; cardiology and neurology, prescription oral dosage products; oral analgesics, both prescription and OTC, and OTC oral and nasal sprays and ophthalmic products.
Taro Canada manufactures more than 70 finished dosage form pharmaceutical products for sale in Canada and for export. It markets and distributes generic products in the local Canadian market. Its product line includes dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology, oncology, gastrointestinal and neurology: prescription oral and injects able dosage products, and allergy (antihistamine): OTC oral dosage products.
Taro U.S.A markets! and distributes generic products in the United States market. Its primary product lines include dermatology: prescription and OTC semi-solid products (creams, ointments and gels) and liquids, cardiology and neurology: prescription oral dosage products, and other prescription and OTC products.
The Company competes with Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer/Wyeth, Valeant, Galderma, Merck/Schering-Plough, Teva Pharmaceuticals U.S.A., Mylan Laboratories, Perrigo Company, Ranbaxy Pharmaceuticals Inc., Sandoz Pharmaceuticals, Merck Canada Inc., Pfizer Canada Inc., Janssen Inc., Schering-Plough Canada, Novartis Pharmaceuticals Canada Inc., GlaxoSmithKline Inc., Bayer Inc., Bristol-Myers Squibb Canada, Apotex Inc., Teva Canada Limited, Mylan Pharmaceuticals ULC, Sandoz Canada Incorporated, Pharmascience Inc., Teva Pharmaceutical Industries Ltd., Perrigo Israel Pharmaceuticals Ltd., Dexxon Ltd., Rafa Laboratories Ltd., Bayer AG, Eli Lilly and Company, Merck & Co., Inc. and Pfizer Inc.
Advisors' Opinion:- [By Ben Levisohn]
Teva has dropped 7.7% to $37.85 today at 3:23 p.m. but doesn’t seem to be spreading though the generic drug space. Taro Pharmaceuticals (TARO) ha gained 1.1% to $79, while Actavis (ACT) has gained 1.2% to $156.25 and Dr. Reddy’s Laboratories (RDY) has advanced 1% to $40.24. Mylan (MYL) has dropped 0.7% to $38.40.
Hot Forestry Stocks To Invest In Right Now: Danone SA (DANOY)
Danone SA, incorporated on February 2, 1899, is a France-based company engaged in food processing activities. The Company operates in four business lines, including Fresh Dairy Products, Waters, Baby Nutrition and Medical Nutrition. The Fresh Dairy Products business line�� brands are Danone, Actimel, Activia, Danacol and Vitalinea. The Water business line offers brands, such as Evian, Volvic, Aqua, Bonafont, Font Vella and Lanjaron. The Baby Nutrition business line include Bledina, Gallia, Nutricia, Cow & Gate, Milupa, Mellin and Dumex brands. Medical nutrition business includes Nutricia, Nutrini, Nutrison, Fortimel, FortiCare, Fortisip, Neocate and Infatrini brands. As of December 31, 2009, the Company acquired Danone Clover and a 26.85% interest in Micropharma. In December 2010, the Company and Unimilk announced the finalization of the merger of their Fresh Dairy Product businesses.
In Europe the Company�� main markets are France, Spain, Germany, Italy, the Benelux countries, the United Kingdom, Poland and Russia. The Company�� product Actimel, the probiotic dairy product, if consumed daily, helps to strengthen the organism�� natural defenses. The Waters business line includes activities focused on natural or flavored mineral water and on fruit-flavored or tea drinks, with a positioning concerned with health benefits. The Company�� baby nutrition business line�� activities consist mainly of producing food for newborns and babies (infant milk formula, follow-on milk, and growing up milk). It also offers a diverse range of products for
children aged 6 to 36 months. Specially developed and clinically tested formulas have also been developed for babies suffering from milk protein intolerance. The Medical Nutrition business line develops nutritional products adapted to specific needs, namely those of hospitalized patients, in order to prevent malnutrition and to improve its consumers daily life.
The Company competes with Nestle, PepsiCo, Coca-cola, Abbott, Mead! Johnson and Fresenius.
Advisors' Opinion:- [By Rich Smith]
On Tuesday, the Seattle coffee company announced that it's teaming up with France's Danone (NASDAQOTH: DANOY ) to begin marketing a "jointly created and developed" selection of specialty yogurt products.
- [By Jim Jubak]
Six milk powder producers, charged by China's National Development and Reform Commission with price fixing, have pled guilty and will be fined 669 million yuan ($109 million.) The companies—Mead Johnson Nutrition (MJN), Danone (DANOY) subsidiary Dumex, Abbott Laboratories (ABT), Fonterra Cooperative Group (FSF:AU), FrieslandCampina, and Biostime International Holdings—admitted they set minimum prices for distributors in order to keep prices high. Many of the companies had earlier cut the prices they charge in China—Fonterra had cut the price of its Anmun brand of baby formula 9%, Abbott Laboratories had reduced prices by as much as 12%, and Mead Johnson had lowered prices by 7% to 15%. This is, CaixinOnline reports, the harshest penalty handed out under China's five-year-old anti-monopoly law. The announcement of the fine, hard on the heels of a ban by China on all imports of whey protein products from Fonterra—after regulators found a batch of whey from a Fonterra plant in New Zealand contaminated with botulism—makes it clear that something big is going on here.
Hot Forestry Stocks To Invest In Right Now: LRAD Corporation(LRAD)
LRAD Corporation engages in the design, development, and commercialization of directed sound technologies and products in North America, Europe, the Middle East, and Asia. The company develops and delivers directed acoustic products that beam, focus, and control sound over short and long distances. It offers Long Range Acoustic Device, which creates directed acoustic beam to communicate at operational ranges in high ambient noise environments, primarily for military applications. The company also provides SoundSaber thin film magnetic speaker technology that provides high clarity throughout the audio range for emergency and mass notification, public address, and other sound applications. Its SoundSaber hardened panels are used in acoustic environments, such as hangar bays, industrial buildings, airports, and other facilities. LRAD Corporation sells its products directly to government, military, large end-users, and defense-related companies. The company was formerly known as American Technology Corporation and changed its name to LRAD Corporation in March 2010. LRAD Corporation was founded in 1980 and is based in San Diego, California.
Advisors' Opinion:- [By gurujx]
LRAD (LRAD): CFO/Secretary Katherine McDermott Sold 38,204 Shares
CFO/Secretary Katherine McDermott sold 38,204 shares of LRAD stock on Aug. 28 at the average price of $1.57. Katherine H McDermott owns at least 17,800 shares after this. The price of the stock has decreased by 10.19% since.
Hot Forestry Stocks To Invest In Right Now: State Auto Financial Corporation(STFC)
State Auto Financial Corporation, through its subsidiaries, writes personal and business lines of insurance to individuals and small-to-medium sized businesses. The company operates through four segments: Personal insurance, Business insurance, Specialty insurance, and Investment operations. The Personal insurance segment provides personal automobile and homeowners insurance products to the personal insurance market. The Business insurance segment offers commercial automobile, commercial multi-peril, fire and allied lines, and general liability insurance covering small-to-medium sized commercial exposures in the business insurance market. The Specialty insurance segment provides commercial coverages requiring specialized product underwriting, workers? compensation, claims handling, or risk management services. The Investment operations segment offers investment portfolio management services. State Auto Financial Corporation markets its insurance products primarily through independent insurance agencies, which include retail agencies and wholesale brokers in 50 states and the District of Columbia. The company was founded in 1950 and is headquartered in Columbus, Ohio. State Auto Financial Corporation is a subsidiary of State Automobile Mutual Insurance Company.
Advisors' Opinion:- [By CRWE]
State Auto Financial Corporation (Nasdaq:STFC), a super regional property and casualty insurance holding company, will discuss its third quarter 2012 results in a conference call on Tuesday, Nov. 6, 2012, at 10 a.m. ET.
Hot Forestry Stocks To Invest In Right Now: Northeast Utilities(NU)
Northeast Utilities, a public utility holding company, provides electric and natural gas energy delivery services to residential, commercial, and industrial customers in Connecticut, New Hampshire, and western Massachusetts. The company engages in the purchase, delivery, and sale of electricity; and owns and operates approximately 1,200 megawatts of primarily fossil-fueled electricity generation assets. As of December 31, 2010, it served approximately 1.2 million customers in 149 cities and towns in Connecticut; 497,000 retail customers in 211 cities and towns in New Hampshire; and 206,000 retail customers in 59 cities and towns in western Massachusetts. The company also operates a natural gas distribution system in Connecticut and serves approximately 206,000 customers in 71 cities and towns. It offers gas supply to commercial and industrial customers; and to residential customers for heating, hot water, and cooking needs, as well as provides gas transportation services t o commercial and industrial customers. In addition, the company offers electric transmission services. Northeast Utilities was founded in 1927 and is headquartered in Hartford, Connecticut.
Advisors' Opinion:- [By David Dittman]
Northeast Utilities (NYSE: NU) is New England�� largest utility system, serving more than 1.7 million electricity customers in Connecticut, Massachusetts and New Hampshire.
- [By Marc Bastow]
Public energy utility holding company Northeast Utilities (NU) raised its quarterly dividend 8.2% to 39.75 cents per share, payable on Mar. 31 to shareholders of record as of Mar. 3.
NU Dividend Yield: 3.67% - [By David Dittman]
The stock is trading well above our recommended buy-under target of 62, an indication that the market doesn’t see any debilitating Dan River problems. So it is effectively a hold at these levels.
If you have money to invest, focus on Northeast Utilities (NSYE: NU), Kinder Morgan Energy Partners and/or TransCanada Corp (TSX: TRP, NYSE: TRP).
No comments:
Post a Comment